Company / EPS (Basic)
Ligand Pharmaceuticals, Inc. EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$3.02
FY2025
5-year range
-$1.98 / $33.13
FY2021-FY2025
Trend
+252.5%
vs FY2024
Sector context
#16 of 208
Health Care
What the data says
EPS (Basic) changed +253% YoY in FY2025, a notable deviation from the 9-year average annual change of +671%.
Based on SEC 10-K filings.
3.02 in FY2025 with a 5-year CAGR of -14.9%. Top quartile in the Health Care sector.
Declined from $3.44 to $3.02 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -14.9%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 208This company $3.02 Sector average -$0.87
▼
+446.9% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 252.5% year-over-year.
- Ranks #16 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2021.
- Lowest eps (basic) in the period was in FY2024.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.02 | +252.5% |
| FY2024 | -$1.98 | -157.6% |
| FY2023 | $3.44 | +2011.1% |
| FY2022 | -$0.18 | -100.5% |
| FY2021 | $33.13 | +389.4% |
| FY2020 | $6.77 | +1028.3% |
| FY2019 | $0.60 | +850.0% |
| FY2018 | -$0.08 | -100.7% |
| FY2017 | $11.61 | +1867.8% |
| FY2016 | $0.59 | +5.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026